Steady-State Pharmacokinetics of Abacavir in Plasma and Intracellular Carbovir Triphosphate following Administration of Abacavir at 600 Milligrams Once Daily and 300 Milligrams Twice Daily in Human Immunodeficiency Virus-Infected Subjects

MLA

Phillip Hay, et al. “Steady-State Pharmacokinetics of Abacavir in Plasma and Intracellular Carbovir Triphosphate Following Administration of Abacavir at 600 Milligrams Once Daily and 300 Milligrams Twice Daily in Human Immunodeficiency Virus-Infected Subjects.” Antimicrobial Agents and Chemotherapy, vol. 53, Apr. 2009, pp. 1532–38. EBSCOhost, https://doi.org/10.1128/aac.01000-08.

APA

Phillip Hay, Sherene S. Min, Yu Lou, Marta Boffito, Graeme Moyle, Ivy Song, Chris Higgs, Elena M. Guerini, Carl Fletcher, & Geoffrey J. Yuen. (2009). Steady-State Pharmacokinetics of Abacavir in Plasma and Intracellular Carbovir Triphosphate following Administration of Abacavir at 600 Milligrams Once Daily and 300 Milligrams Twice Daily in Human Immunodeficiency Virus-Infected Subjects. Antimicrobial Agents and Chemotherapy, 53, 1532–1538. https://doi.org/10.1128/aac.01000-08

Chicago

Phillip Hay, Sherene S. Min, Yu Lou, Marta Boffito, Graeme Moyle, Ivy Song, Chris Higgs, Elena M. Guerini, Carl Fletcher, and Geoffrey J. Yuen. 2009. “Steady-State Pharmacokinetics of Abacavir in Plasma and Intracellular Carbovir Triphosphate Following Administration of Abacavir at 600 Milligrams Once Daily and 300 Milligrams Twice Daily in Human Immunodeficiency Virus-Infected Subjects.” Antimicrobial Agents and Chemotherapy 53 (April): 1532–38. doi:10.1128/aac.01000-08.